Global Medisciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 4.06 M
as on 16-11-2024
- Company Age 21 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 6.60 Cr
as on 16-11-2024
- Revenue 2.31%
(FY 2023)
- Profit 12.95%
(FY 2023)
- Ebitda 6.96%
(FY 2023)
- Net Worth -2.12%
(FY 2023)
- Total Assets -1.80%
(FY 2023)
About Global Medisciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.06 M.
The company has closed loans amounting to ₹6.60 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vivek Rajgarhia, Vishal Rajgarhia, and Vikash Rajgarhia serve as directors at the Company.
- CIN/LLPIN
U24239GJ2003PLC056518
- Company No.
056518
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 Jun 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Global Medisciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Rajgarhia  | Director | 01-Feb-2007 | Current |
| Vishal Rajgarhia | Director | 20-Jun-2003 | Current |
| Vikash Rajgarhia | Director | 15-Jul-2010 | Current |
Financial Performance of Global Medisciences.
Global Medisciences Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.31% increase. The company also saw a substantial improvement in profitability, with a 12.95% increase in profit. The company's net worth dipped by a decrease of 2.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Global Medisciences?
In 2023, Global Medisciences had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Finecure Pharmaceuticals LimitedActive 19 years 9 monthsVivek Rajgarhia, Vishal Rajgarhia and 1 more are mutual person
- Finecure FoundationActive 3 years 10 months
Vivek Rajgarhia, Vishal Rajgarhia and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Kotak Mahindra Bank Limited Creation Date: 20 Jun 2014 | ₹5.25 Cr | Satisfied |
Centurion Bank Of Punjab Limited Creation Date: 28 Feb 2008 | ₹2.90 M | Satisfied |
Icici Bank Ltd. Creation Date: 31 Jan 2007 | ₹1.06 Cr | Satisfied |
How Many Employees Work at Global Medisciences?
Unlock and access historical data on people associated with Global Medisciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Global Medisciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Global Medisciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
